Top Stories

Bayer, Arvinas Launch Joint Venture for Targeted Protein Degradation Products

The new joint venture, named Oerth Bio, will use Arvinas’ Protac technology to develop innovative new agricultural products. As part of its collaboration with Arvinas, Bayer is also using this technology to develop human therapeutics
/ read more /

GSK Invests $120 million in US Biopharmaceutical Manufacturing Facility

GSK’s expanded R&D and manufacturing facility in Upper Merion, PA houses a new analytical lab and flexible manufacturing equipment, including single-use bioreactors.
/ read more /

Industry News

Novartis Collaborates with Microsoft for AI
Innovation Lab

The companies agreed to a multi-year research and development collaboration that will focus on AI empowerment and exploration.
/ read more /

Regen Shows Positive Data for CBD Arthritis Treatment

Data showed that the drug candidate activated T regulatory cells, believed to serve a crucial role in protecting the body from uncontrolled inflammation or autoimmunity.
/ read more /

Biopharma News

GSK Completes Retrofit of Maryland Facility

GSK invested $139 million to its Rockville, MD site to support demand for Benlysta.
/ read more /

Astellas Invests $13 Million into Innovation
Facilities for Cell and Gene Therapy

The new incubators are set to be operational starting in 2021.
/ read more /

Supplier News

Lonza Enters Manufacturing Agreement with
Cellectis for CAR T Cell Development

Manufacturing of the cell line will take place at Lonza’s GMP facility in Geleen, Netherlands.
/ read more /

TrakCel Forms Cell and Gene Therapy Supply Partnership with WuXi AppTec

The partnership combines global CDMO services with a cellular orchestration platform.
/ read more /

Regulatory News

FDA Releases New Bioanalytical Methods Tables for New Drug and Biologic Applications

The tables can be used for new drug applications, biologics license applications, and supplements to these applications
/ read more /